Chapter 284 Oncolytic Generation Clinical Trial Ended
After people's life expectancy is extended so much, the social status quo will be completely changed.
You may have children after you are 100 years old.
There may be more time to study and work.
Imagine a person who can continue to learn, or work for four or five hundred years.
At that time, everyone's knowledge and experience will be incomparably rich.
In this state, even without Zhang Chen's boost, the level of human science and technology will steadily improve.
This is the self-driving force brought about by the development of science and technology.
Within a few days, Huang Ruifang and Liu Qiang completed the safety evaluation experiment of the oncolytic virus project.
With the help of Tian Wenbin, this project submitted a clinical application.
Zhang Chen named the oncolytic virus project product this time as the oncolytic generation.
Li Hanhai, director of the General Administration of CDE, personally called Zhang Chen and said that the review would be completed in a few days.
And the audit team is still the original team of the last audit of Lanyue 001.
Li Hanhai's arrangement is to speed up the review progress of the oncolytic virus project.
Countless people in the country are troubled by lung cancer and stomach cancer every year, and Li Hanhai's father died of lung cancer.
Coupled with the magical performance of the previous Lanyue 001.
Li Hanhai has given great convenience and expectation to this drug of Chenyue Group.
Xu Zeming also helped Zhang Chen arrange the hospital in the capital as soon as possible.
As long as the clinical trial is approved, it can enter the formal clinical trial as soon as possible.
Zhang Chen's side also asked people to arrange clinical trials in hospitals in other regions. @η²Ύε\/Shuge Error-free Debut~~
Two major cancers have now been solved, but there are many others waiting for them to conquer.
Zhang Chen didn't plan to develop them one by one, he directly exchanged all the oncolytic virus therapies for cancers that humans could get.
He wants to conquer all cancers at once.
It also includes glioma, a rare cancer with a high mortality rate.
Because ordinary drugs cannot cross the blood-brain barrier, the mortality rate of glioma is the highest among all cancers.
Don't look at the quantity, but the cost of including simulation data is less than 10,000 points.
It can be seen that oncolytic virus therapy is a relatively backward scientific and technological means in the system.
When Zhang Chen forwarded these materials to Huang Ruifang and Liu Qiang, the two of them directly widened their eyes.
Huang Ruifang was so frightened that the mineral water bottles fell directly to the ground.
Not only because of the large number, but also because she wanted to break her head, she couldn't imagine where Zhang Chen got these technical materials.
This is not at all what a young man in his twenties should have.
Even if you are an expert in oncolytic viruses in China, you can't do it to this terrible level.
Although the credibility of these data is not yet known, it is based on the terrifying effects of the previous lung cancer and stomach cancer products.
These products given by Zhang Chen, their therapeutic effects will definitely not be worse than the previous two products.
Looking at the shocked expressions of the two, Zhang Chen smiled slightly.
"Don't think about it, these products still need to be optimized, and you don't have to be too anxious, you can try to integrate them one by one.
I don't ask you to have your own ideas, you just need to do some validation experiments, get specific results, and finally put them together to apply for clinical trials.
Our goal is to make an oncolytic virus product that can treat all cancers in humans, can you do it? β
Huang Ruifang and Liu Qiang glanced at each other, the two were not people who gave up easily.
And after such a large-scale project, they must have learned a lot of real skills in oncolytic viruses.
Out of love for scientific research, the two embarked on the road of no return to scientific research to study for a doctorate.
There were a plethora of unknown challenges waiting for both of them, and they didn't even think about missing out on this opportunity.
"Okay, Mr. Zhang, we will definitely complete the task well!"
Liu Qiang said loudly, like a recruit reporting to the old squad leader. (This chapter is not finished!) )
Chapter 284 Oncolytic Generation Clinical Trial Ended
time.
Huang Ruifang, who was on the side, also nodded fiercely with a serious face.
It's going to be a big challenge for them.
Succeeded, and the two of them were heroes who conquered cancer.
Looking at Zhang Chen, whose expression was very casual, Huang Ruifang inexplicably felt that they had a high chance of success.
So, she and Liu Qiang once again devoted themselves to intense research and development.
Even the clinical trials of the oncolytic generation, they did not pay attention to it, and devoted themselves to the research and development of new projects.
Zhang Chen did not participate in the clinical trials of the oncolytic generation again.
After Lanyue 001, many people in the company have a full understanding of the entire process of clinical trials.
This time, Zhang Chen didn't have to worry about it at all.
On November 15, the phase I clinical trial of the oncolytic generation came to a perfect end.
In the entire phase I clinical trial, a total of 100 volunteer subjects were completely cured.
Like the phase I clinical trial of Lanyue 001, Zhang Chen gave a large amount of condolences to the 100 subjects.
And the powerful drug effect of the oncolytic generation has also spread rapidly under people's word of mouth. Error-free updates @
At the time of clinical trials in the oncolytic generation.
Some people began to appear on the Internet, and they deliberately promoted the uselessness of Golden Harvest series products everywhere.
Zhang Chen was not used to these small things, he asked Geng Hao to cooperate with the relevant state departments and do his best to crack down on these people.
But such rats can never be eliminated.
Zhang Chen looked at these remarks, although he didn't pay too much attention to them, he still felt that they were very eyesore.
Without saying a word, he spent 100,000 points in the system to exchange for a network monitoring device.
This device is a purely physical high-tech product, and its technological level is at least hundreds of years beyond the current technological level.
It can shield and tamper with any information on the Internet according to needs, and it integrates attack and defense.
It can be said that it is a super hacking technology product that is suitable for any novice.
After redeeming this product, the Internet immediately fell silent.
All the malicious remarks against the Chenyue Group disappeared inexplicably.
Even the platform's backend data has not left any trace of these remarks.
Some people don't give up and want to continue to spread rumors.
But the rumor-mongering that had just been sent out was cleared up in an instant.
And shortly after these people made these remarks, they received Geng Hao's lawyer's letter.
After exchanging the network monitoring device, Zhang Chen no longer cared about these things.
Seeing that the phase I clinical trial of the oncolytic generation was going well, Zhang Chen temporarily decided to speed up the clinical trial.
Li Hanhai, director of the CDE, did not oppose Zhang Chen's decision, and he also wanted to see this drug go on the market as soon as possible.
As a result, the progress of clinical trials began to advance rapidly.
On November 25, all clinical trials of the oncolytic generation ended perfectly.
There were no accidents on the way, Zhang Chen thought that there would be the same framing incident as Lanyue 001.
But until the end, it didn't appear.,It's estimated that I was scared before.γγ
Chapter 284 Oncolytic Generation Clinical Trial Ended